common
cold
common
infecti
diseas
affect
human
common
cold
viral
upper
respiratori
tract
infect
typic
symptom
includ
nasal
congest
rhinorrhoea
sneez
sore
throat
cough
mani
virus
caus
common
cold
human
rhinovirus
hrv
frequent
pathogen
averag
adult
two
four
cold
per
year
mean
durat
symptom
common
cold
report
seven
ten
day
usual
selflimit
diseas
howev
common
cold
caus
signific
morbid
substanti
econom
impact
societi
usa
alon
noninfluenza
viral
respiratori
tract
infect
caus
estim
million
lost
workday
million
physician
visit
million
emerg
depart
visit
annual
produc
econom
burden
billion
year
furthermor
hrv
infect
pose
particular
risk
comorbid
asthma
chronic
obstruct
pulmonari
diseas
copd
major
caus
diseas
exacerb
effect
treatment
identifi
common
cold
current
treatment
mainli
symptomat
mani
cold
remedi
market
exampl
usa
estim
billion
spent
overthecount
medic
common
cold
annual
amongst
treatment
use
zinc
vitamin
c
nasal
decongest
nonsteroid
antiinflammatori
drug
nsaid
echinacea
antihistamin
antibiot
heat
humidifi
air
evid
effect
mani
inconclus
demonstr
limit
benefit
symptom
reduct
rhinothermi
hrv
caus
two
third
cold
importantli
hypothesi
test
research
temperaturedepend
replic
antivir
effect
temperatur
hrv
investig
vitro
replic
hrv
strain
optim
normal
physiolog
temperatur
upper
airway
studi
report
rais
nasal
mucos
temperatur
may
inhibit
viral
replic
may
treatment
strategi
attenu
sever
durat
common
cold
symptom
forstal
colleagu
report
greatest
inhibit
hrv
occur
expos
temperatur
least
one
hour
f
r
p
e
e
r
r
e
v
e
w
n
l
conti
colleagu
report
hrv
replic
suppress
expos
temperatur
minut
rhinothermi
deliveri
heat
humidifi
air
upper
airway
via
nasal
passag
studi
conduct
vivo
deliv
heat
humidifi
air
particip
rang
temperatur
use
varieti
devic
includ
anaesthet
mask
steamvent
nozzl
held
distanc
away
nare
deliveri
system
may
ineffici
inconsist
deliv
humidifi
air
upper
airway
desir
temperatur
recent
cochran
systemat
review
six
rhinothermi
studi
particip
common
cold
treat
heat
humidifi
air
show
harm
benefit
advis
cautiou
interpret
evid
conclud
qualiti
low
grade
review
recommend
doubleblind
randomis
control
trial
need
provid
definit
diagnosi
deriv
viral
cultur
use
uniform
symptom
score
evid
futur
trial
use
standardis
treatment
modal
effect
consist
rais
temperatur
upper
airway
durat
treatment
technic
difficulti
deliv
heat
humidifi
air
upper
airway
effici
toler
manner
overcom
nasal
high
flow
rhinothermi
rnhf
devic
manufactur
fisher
paykel
healthcar
ltd
auckland
new
zealand
devic
consist
deliv
highflow
humidifi
air
heat
upper
airway
devic
well
toler
accept
adult
recent
feasibl
studi
recruit
particip
symptom
common
cold
randomis
control
trial
rct
five
day
rnhf
therapi
vitamin
c
main
patient
report
outcom
measur
modifi
jackson
score
rnhf
therapi
deliv
humidifi
air
two
hour
daili
compar
vitamin
c
rnhf
treatment
caus
clinic
signific
five
unit
reduct
modifi
jackson
score
follow
feasibl
studi
plan
undertak
definit
adequ
power
rct
investig
effect
rnhf
treatment
manag
common
cold
five
day
nasal
high
flow
rhinothermi
rnhf
therapi
effect
reduc
symptom
sever
durat
common
cold
five
day
sham
rhinothermi
randomis
singleblind
parallelgroup
trial
compar
five
day
rnhf
therapi
humidifi
air
c
two
hour
daili
sham
rhinothermi
therapi
humidifi
air
c
ten
minut
daili
treatment
common
cold
plan
recruit
particip
within
hour
onset
specif
symptom
common
cold
particip
randomis
receiv
one
two
possibl
treatment
arm
receiv
treatment
first
five
day
studi
studi
visit
occur
day
day
followup
phone
call
day
patient
report
outcom
measur
modifi
jackson
score
mj
studi
data
collect
record
use
electron
data
captur
tool
redcap
research
electron
data
captur
mj
day
collect
investig
part
screen
visit
particip
complet
daili
symptom
diari
includ
daili
mj
remot
enter
data
directli
either
electron
case
report
form
ecrf
redcap
paper
age
year
investig
opinion
abl
will
compli
trial
requir
onset
symptom
within
last
hour
time
consent
mj
nasal
condit
deviat
septum
chronic
rhiniti
investig
consid
could
impair
nasal
breath
current
use
requir
oral
antibiot
respiratori
tract
infect
pneumonia
infect
exacerb
underli
respiratori
condit
current
use
requir
parenter
antibiot
daili
intranas
inhal
steroid
allow
part
particip
regular
therapi
taken
prior
enrol
withheld
durat
studi
implant
medic
devic
notifi
diseas
exist
travel
plan
requir
leav
greater
wellington
region
first
day
studi
period
particip
use
rhinothermi
devic
current
diagnosi
asthma
chronic
obstruct
pulmonari
diseas
copd
signific
respiratori
condit
particip
asthma
symptom
requir
asthma
medic
within
last
month
elig
inclus
studi
posit
pointofcar
test
influenza
b
investig
believ
particip
care
giver
unabl
safe
use
rnhf
without
medic
supervis
condit
investig
discret
believ
may
present
safeti
risk
impact
feasibl
studi
studi
result
initi
screen
visit
take
place
mrinz
studi
clinic
involv
calcul
symptom
durat
day
baselin
mj
assess
presenc
exclus
criteria
obtain
past
medic
surgic
smoke
allergi
medic
histori
collect
nasopharyng
specimen
exclud
influenza
b
virus
physic
examin
ensur
physic
health
issu
may
exclud
particip
studi
inform
consent
obtain
prior
screen
prior
enrol
studi
elig
particip
particip
sign
electron
consent
form
redcap
nasopharyng
specimen
obtain
screen
visit
use
copan
flock
swab
specimen
test
presenc
influenza
type
b
viru
nucleic
acid
use
xpress
flursv
pointofcar
test
cepheid
ca
usa
sensit
specif
realtim
pcr
use
xpress
flursv
pointofcar
test
rapid
diagnosi
influenza
viru
report
respect
nasopharyng
specimen
obtain
enrol
particip
also
sent
canterburi
permut
block
randomis
method
stratifi
durat
ill
lesser
versu
greater
equal
one
day
use
alloc
particip
either
treatment
arm
computergener
sequenc
suppli
studi
statistician
independ
investig
ecrf
system
conceal
alloc
releas
particip
randomis
outcom
time
randomis
randomis
schedul
access
studi
statistician
ecrf
provid
studi
staff
access
randomis
schedul
two
randomis
treatment
f
r
p
e
e
r
r
e
v
e
w
n
l
encourag
selfadminist
sham
rhinothermi
singl
minut
session
day
treatment
contrast
recent
feasibl
studi
sham
rhinothermi
use
control
rather
vitamin
c
use
sham
rhinothermi
control
arm
provid
advantag
mask
particip
treatment
alloc
control
placebo
effect
associ
use
rhinothermi
devic
rational
sham
devic
set
produc
treatment
unlik
therapeut
effect
respiratori
pathogen
temperaturedepend
replic
temperatur
inhibit
viral
replic
gener
safeti
check
complet
devic
provid
use
particip
also
ask
read
relev
devic
warn
person
sign
date
document
read
understood
intervent
control
devic
automat
record
devic
use
data
electron
adher
rnhf
sham
rhinothermi
treatment
assess
investig
review
data
adher
rnhf
defin
minimum
minut
use
per
day
deliv
session
per
day
adher
sham
rhinothermi
defin
minimum
minut
use
per
day
deliv
singl
session
day
mj
calcul
part
screen
visit
particip
ask
complet
daili
symptom
diari
onlin
subsequ
day
link
daili
symptom
diari
gener
redcap
sent
particip
via
autom
email
text
daili
symptom
diari
data
enter
directli
redcap
particip
particip
without
comput
internet
access
provid
paper
version
daili
symptom
diari
use
electron
paper
symptom
diari
figur
particip
document
daili
mj
feel
day
either
lot
wors
littl
wors
littl
better
lot
better
compar
day
day
studi
return
usual
daili
activ
f
r
p
e
e
r
r
e
v
e
w
n
l
use
cold
medicationsremedi
provid
detail
applic
noncomplet
onlin
symptom
diari
trigger
remind
redcap
particip
return
mrinz
studi
clinic
second
visit
return
devic
complet
toler
questionnair
regard
devic
treatment
new
medic
advers
event
devic
issu
also
review
visit
particip
administ
day
treatment
rnhf
sham
rhinothermi
time
attend
encourag
receiv
alloc
treatment
day
visit
investig
download
devic
use
data
particip
devic
upload
redcap
day
followup
phone
call
particip
receiv
follow
phone
call
final
day
studi
day
review
new
medic
advers
event
devic
issu
confirm
end
studi
particip
ask
provid
feedback
consid
appropri
studi
reimburs
arrang
sent
primari
object
estim
differ
sever
symptom
common
cold
rnhf
sham
rhinothermi
day
test
hypothesi
rnhf
superior
sham
rhinothermi
primari
outcom
measur
estim
differ
durat
symptom
common
cold
day
rnhf
day
sham
rhinothermi
estim
differ
time
feel
littl
better
lot
better
compar
day
rnhf
day
sham
rhinothermi
estim
differ
time
return
normal
daili
activ
day
rnhf
day
sham
rhinothermi
estim
interact
treatment
effect
hrv
viral
statu
mj
day
inclus
time
feel
littl
better
compar
studi
entri
day
time
feel
lot
better
compar
studi
entri
day
time
resolut
symptom
defin
start
hour
period
mj
remain
hour
time
return
normal
daili
activ
record
daili
symptom
diari
mj
day
particip
whose
nasopharyng
specimen
hrv
posit
toler
questionnair
result
devic
use
data
download
rnhf
devic
statist
analys
use
intent
treat
principl
particip
randomis
includ
analysi
primari
comparison
rnhf
treatment
sham
rhinothermi
treatment
primari
outcom
variabl
analys
ancova
day
baselin
mj
covari
interact
analysi
use
assess
evid
differ
treatment
outcom
particip
test
posit
hrv
type
error
rate
primari
analysi
pvalu
deviat
origin
statist
plan
describ
justifi
protocol
final
report
appropri
recent
randomis
control
trial
rnhf
compar
vitamin
c
reduct
mj
repres
substanti
clinic
benefit
upper
confid
limit
standard
deviat
trial
sampl
size
group
allow
detect
differ
unit
power
type
error
rate
allow
dropout
rate
total
particip
randomis
group
interim
analysi
protocol
approv
health
disabl
ethic
committe
new
zealand
investig
ensur
trial
conduct
accord
principl
declar
helsinki
good
clinic
practic
advers
event
devic
defici
report
studi
sponsor
accord
current
local
nation
advers
event
report
polici
sponsor
manag
devic
defici
report
part
ongo
postmarket
safeti
review
process
sponsor
report
advers
event
relev
investig
devic
defici
regulatori
author
princip
investig
pi
within
requir
time
period
accord
current
report
requir
data
safeti
monitor
committe
dsmc
appoint
review
sae
expedit
basi
ensur
adequ
studi
safeti
review
enrol
withdraw
ae
everi
six
month
dsmc
may
recommend
sponsor
studi
termin
howev
final
decis
made
sponsor
pi
correspond
author
full
access
studi
data
final
respons
submit
report
public
pi
also
take
respons
report
result
particip
express
would
like
receiv
studi
result
sponsor
involv
collect
analysi
interpret
data
prepar
report
decis
submit
public
modifi
jackson
symptom
score
particip
daili
symptom
diari
grace
bird
wrote
current
hdec
approv
version
protocol
protocol
manuscript
input
iren
braithwait
jame
fingleton
richard
beasley
iren
braithwait
jame
fingleton
alex
semprini
design
studi
direct
project
mark
weatheral
design
verifi
randomis
schedul
statist
analysi
method
meik
dilcher
lanc
jen
advis
collect
laboratori
analysi
nasopharyng
specimen
steve
mckinstri
investig
rhinothermi
common
cold
feasibl
studi
contribut
develop
protocol
jame
harper
iri
koorevaar
contribut
protocol
amend
studi
fund
fisher
paykel
healthcar
limit
fph
fph
also
provid
rhinothermi
sham
rhinothermi
devic
associ
consum
author
compet
interest
declar
data
may
avail
request
correspond
author
common
cold
common
infecti
diseas
affect
human
usual
selflimit
diseas
howev
common
cold
caus
signific
morbid
substanti
econom
impact
societi
human
rhinovirus
hrv
caus
two
third
cold
temperaturedepend
replic
hrv
strain
replic
optim
deliveri
heat
humidifi
air
upper
airway
potenti
reduc
viral
replic
evid
effect
treatment
common
cold
inconclus
plan
test
hypothesi
deliveri
humidifi
air
heat
high
flow
nasal
high
flow
rhinothermi
rnhf
two
hour
daili
five
day
effect
reduc
common
cold
symptom
sever
durat
five
day
sham
rhinothermi
randomis
singleblind
parallelgroup
trial
compar
rnhf
sham
rhinothermi
treatment
common
cold
plan
recruit
particip
within
hour
onset
symptom
common
cold
randomis
receiv
one
two
treatment
five
day
studi
durat
day
includ
clinic
visit
first
day
randomis
four
day
postrandomis
phone
call
fourteenth
day
particip
complet
daili
symptom
diari
includ
symptom
score
modifi
jackson
score
mj
primari
outcom
modifi
jackson
score
mj
four
day
new
zealand
ethic
registr
result
publish
peerreview
medic
journal
present
academ
meet
report
particip
flow
rate
use
rnhf
devic
enhanc
deliveri
heat
humidifi
air
upper
airway
use
sham
rhinothermi
ensur
appropri
control
treatment
nasopharyng
sampl
allow
subgroup
analysi
subject
polymeras
chain
reaction
pcr
posit
specif
respiratori
pathogen
possibl
blind
investig
intervent
administ
common
cold
common
infecti
diseas
affect
human
common
cold
viral
upper
respiratori
tract
infect
typic
symptom
includ
nasal
congest
rhinorrhoea
sneez
sore
throat
cough
mani
virus
caus
common
cold
human
rhinovirus
hrv
frequent
pathogen
averag
adult
two
four
cold
per
year
mean
durat
symptom
common
cold
report
seven
ten
day
usual
selflimit
diseas
howev
common
cold
caus
signific
morbid
substanti
econom
impact
societi
usa
alon
noninfluenza
viral
respiratori
tract
infect
caus
estim
million
lost
workday
million
physician
visit
million
emerg
depart
visit
annual
produc
econom
burden
billion
year
furthermor
hrv
infect
pose
particular
risk
comorbid
asthma
chronic
obstruct
pulmonari
diseas
copd
major
caus
diseas
exacerb
effect
treatment
identifi
common
cold
current
treatment
mainli
symptomat
mani
cold
remedi
market
exampl
usa
estim
billion
spent
overthecount
medic
common
cold
annual
amongst
treatment
use
zinc
vitamin
c
nasal
decongest
nonsteroid
antiinflammatori
drug
nsaid
echinacea
antihistamin
antibiot
heat
humidifi
air
evid
effect
mani
inconclus
demonstr
limit
benefit
symptom
reduct
rhinothermi
hrv
caus
two
third
cold
importantli
hypothesi
test
research
temperaturedepend
replic
antivir
effect
temperatur
hrv
investig
vitro
replic
hrv
strain
optim
normal
physiolog
temperatur
upper
airway
studi
report
rais
nasal
mucos
temperatur
may
inhibit
viral
replic
may
treatment
strategi
attenu
sever
durat
common
cold
symptom
forstal
colleagu
report
greatest
inhibit
hrv
occur
expos
temperatur
least
one
hour
conti
colleagu
report
hrv
replic
suppress
expos
temperatur
minut
rhinothermi
deliveri
heat
humidifi
air
upper
airway
via
nasal
passag
studi
conduct
vivo
deliv
heat
humidifi
air
particip
rang
temperatur
use
varieti
devic
includ
anaesthet
mask
steamvent
nozzl
held
distanc
away
nare
deliveri
system
may
ineffici
inconsist
deliv
humidifi
air
upper
airway
desir
temperatur
recent
cochran
systemat
review
six
rhinothermi
studi
particip
common
cold
treat
heat
humidifi
air
show
harm
benefit
advis
cautiou
interpret
evid
conclud
qualiti
low
grade
review
recommend
doubleblind
randomis
control
trial
need
provid
definit
diagnosi
deriv
viral
cultur
use
uniform
symptom
score
evid
futur
trial
use
standardis
treatment
modal
effect
consist
rais
temperatur
upper
airway
durat
treatment
recent
feasibl
studi
recruit
particip
symptom
common
cold
randomis
control
trial
rct
five
day
rnhf
therapi
vitamin
c
main
patient
report
outcom
measur
modifi
jackson
score
rnhf
therapi
deliv
humidifi
air
two
hour
daili
compar
vitamin
c
rnhf
treatment
caus
clinic
signific
five
unit
reduct
modifi
jackson
score
follow
feasibl
studi
plan
undertak
definit
adequ
power
rct
investig
effect
rnhf
treatment
manag
common
cold
five
day
nasal
high
flow
rhinothermi
rnhf
therapi
effect
reduc
symptom
sever
durat
common
cold
five
day
sham
rhinothermi
randomis
singleblind
parallelgroup
trial
compar
five
day
rnhf
therapi
humidifi
air
c
two
hour
daili
sham
rhinothermi
therapi
humidifi
air
c
ten
minut
daili
treatment
common
cold
plan
recruit
particip
within
hour
onset
specif
symptom
common
cold
particip
randomis
receiv
one
two
possibl
treatment
arm
receiv
treatment
first
five
day
studi
studi
visit
occur
day
day
followup
phone
call
day
patient
report
outcom
measur
modifi
jackson
score
mj
studi
data
collect
record
use
electron
data
captur
tool
redcap
research
electron
data
captur
mj
day
collect
investig
part
screen
visit
particip
complet
daili
symptom
diari
includ
daili
mj
remot
enter
data
directli
either
electron
case
report
form
ecrf
redcap
paper
age
year
investig
opinion
abl
will
compli
trial
requir
onset
symptom
within
last
hour
time
consent
nasal
condit
deviat
septum
chronic
rhiniti
investig
consid
could
impair
nasal
breath
current
use
requir
oral
antibiot
respiratori
tract
infect
pneumonia
infect
exacerb
underli
respiratori
condit
current
use
requir
parenter
antibiot
daili
intranas
inhal
steroid
allow
part
particip
regular
therapi
taken
prior
enrol
withheld
durat
studi
implant
medic
devic
notifi
diseas
exist
travel
plan
requir
leav
greater
wellington
region
first
day
studi
period
particip
use
rhinothermi
devic
current
diagnosi
asthma
chronic
obstruct
pulmonari
diseas
copd
signific
respiratori
condit
particip
asthma
symptom
requir
asthma
medic
within
last
month
elig
inclus
studi
posit
pointofcar
test
influenza
b
investig
believ
particip
care
giver
unabl
safe
use
rnhf
without
medic
supervis
condit
investig
discret
believ
may
present
safeti
risk
impact
feasibl
studi
studi
result
screen
studi
visit
follow
standardis
schedul
procedur
tabl
initi
screen
visit
take
place
mrinz
studi
clinic
involv
calcul
symptom
durat
day
baselin
mj
assess
presenc
exclus
criteria
obtain
past
medic
surgic
smoke
allergi
medic
histori
collect
nasopharyng
specimen
exclud
influenza
b
virus
physic
examin
ensur
physic
health
issu
may
exclud
particip
studi
enrol
particip
ask
refrain
use
overthecount
medic
vitamin
herbal
remedi
specif
common
cold
symptom
relief
use
medic
constitut
reason
withdraw
document
alongsid
collect
particip
data
either
investig
studi
visit
particip
daili
symptom
diari
nasopharyng
specimen
obtain
screen
visit
use
copan
flock
swab
follow
screen
process
elig
particip
enrol
studi
immedi
randomis
one
follow
treatment
arm
nasal
high
flow
rhinothermi
rnhf
particip
b
sham
rhinothermi
particip
permut
block
randomis
method
stratifi
durat
ill
lesser
versu
greater
equal
one
day
use
alloc
particip
either
treatment
arm
computergener
sequenc
suppli
studi
statistician
independ
investig
ecrf
system
conceal
alloc
releas
particip
randomis
outcom
time
randomis
randomis
schedul
access
studi
statistician
ecrf
provid
studi
staff
access
randomis
schedul
two
randomis
treatment
contrast
recent
feasibl
studi
sham
rhinothermi
use
control
rather
vitamin
c
use
sham
rhinothermi
control
arm
provid
advantag
mask
particip
treatment
alloc
control
placebo
effect
associ
use
rhinothermi
devic
rational
sham
devic
set
produc
treatment
unlik
therapeut
effect
respiratori
pathogen
temperaturedepend
replic
temperatur
inhibit
viral
replic
gener
safeti
check
complet
devic
provid
use
particip
also
ask
read
relev
devic
warn
person
sign
date
document
read
understood
intervent
control
devic
automat
record
devic
use
data
electron
adher
rnhf
sham
rhinothermi
treatment
assess
investig
review
data
adher
rnhf
defin
minimum
minut
use
per
day
deliv
session
per
day
adher
sham
rhinothermi
defin
minimum
minut
use
per
day
deliv
singl
session
day
mj
calcul
part
screen
visit
particip
ask
complet
daili
symptom
diari
onlin
subsequ
day
link
daili
symptom
diari
gener
redcap
sent
particip
via
autom
email
text
daili
symptom
diari
data
enter
directli
redcap
particip
particip
without
comput
internet
access
provid
paper
version
daili
symptom
diari
use
electron
paper
symptom
diari
figur
particip
document
daili
mj
feel
day
either
lot
wors
littl
wors
littl
better
lot
better
compar
day
day
studi
return
usual
daili
activ
noncomplet
onlin
symptom
diari
trigger
remind
redcap
particip
return
mrinz
studi
clinic
second
visit
return
devic
complet
toler
questionnair
regard
devic
treatment
new
medic
advers
event
devic
issu
also
review
visit
particip
administ
day
treatment
rnhf
sham
rhinothermi
time
attend
encourag
receiv
alloc
treatment
day
visit
investig
download
devic
use
data
particip
devic
upload
redcap
day
followup
phone
call
particip
receiv
follow
phone
call
final
day
studi
day
review
new
medic
advers
event
devic
issu
confirm
end
studi
particip
ask
provid
feedback
consid
appropri
studi
reimburs
arrang
sent
primari
object
estim
differ
sever
symptom
common
cold
rnhf
sham
rhinothermi
day
test
hypothesi
rnhf
superior
sham
rhinothermi
primari
outcom
measur
estim
differ
durat
symptom
common
cold
day
rnhf
day
sham
rhinothermi
estim
differ
time
feel
littl
better
lot
better
compar
day
rnhf
day
sham
rhinothermi
estim
differ
time
return
normal
daili
activ
day
rnhf
day
sham
rhinothermi
mj
day
inclus
time
feel
littl
better
compar
studi
entri
day
time
feel
lot
better
compar
studi
entri
day
time
resolut
symptom
defin
start
hour
period
mj
remain
hour
time
return
normal
daili
activ
record
daili
symptom
diari
mj
day
particip
whose
nasopharyng
specimen
hrv
posit
toler
questionnair
result
devic
use
data
download
rnhf
devic
statist
analys
use
intent
treat
principl
particip
randomis
includ
analysi
primari
comparison
rnhf
treatment
sham
rhinothermi
treatment
primari
outcom
variabl
analys
ancova
day
baselin
mj
covari
interact
analysi
use
assess
evid
differ
treatment
outcom
particip
test
posit
hrv
sensit
analysi
use
assess
evid
interact
adher
primari
outcom
type
error
rate
primari
analysi
pvalu
deviat
origin
statist
plan
describ
justifi
protocol
final
report
appropri
recent
randomis
control
trial
rnhf
compar
vitamin
c
reduct
mj
repres
substanti
clinic
benefit
upper
confid
limit
standard
deviat
trial
sampl
size
group
allow
detect
differ
unit
power
type
error
rate
feasibl
studi
dropout
rate
zero
howev
even
though
likelihood
dropout
studi
low
order
ensur
studi
remain
adequ
power
allow
dropout
rate
power
calcul
allow
dropout
rate
total
particip
randomis
group
interim
analysi
protocol
approv
health
disabl
ethic
committe
new
zealand
region
advisori
group
ragm
local
approv
obtain
indic
public
interest
conduct
research
investig
treatment
common
cold
reduct
symptom
sever
durat
prioriti
individu
common
cold
studi
includ
outcom
measur
investig
effect
rhinothermi
symptom
sever
durat
ill
recent
feasibl
studi
involv
particip
provid
inform
relat
effect
recruit
method
toler
devic
adher
feasibl
studi
shown
rhinothermi
devic
well
toler
howev
consolid
find
assess
treatment
burden
studi
includ
outcom
measur
look
adher
toler
treatment
particip
also
encourag
provid
feedback
rais
concern
regard
aspect
studi
complet
result
studi
submit
public
result
also
dissemin
particip
indic
wish
receiv
particip
elig
monetari
reimburs
complet
studi
standard
agre
amount
decid
upon
cover
expens
associ
particip
studi
particip
elig
reimburs
complet
studi
amount
either
full
agre
amount
complet
studi
entireti
reduc
amount
proport
involv
studi
princip
investig
submit
chang
relev
parti
includ
studi
funder
substanti
amend
origin
approv
document
submit
health
investig
ensur
trial
conduct
accord
principl
declar
helsinki
good
clinic
practic
sponsor
fisher
paykel
healthcar
ltd
monitor
studi
accord
procedur
review
seriou
advers
event
advers
event
devic
defici
report
studi
sponsor
accord
current
local
nation
advers
event
report
polici
sponsor
manag
devic
defici
report
part
ongo
postmarket
safeti
review
process
sponsor
report
advers
event
relev
investig
devic
defici
regulatori
author
princip
investig
pi
within
requir
time
period
accord
current
report
requir
data
safeti
monitor
committe
dsmc
appoint
review
sae
expedit
basi
ensur
adequ
studi
safeti
review
enrol
withdraw
ae
everi
six
month
dsmc
may
recommend
sponsor
studi
termin
howev
final
decis
made
sponsor
pi
correspond
author
full
access
studi
data
final
respons
submit
report
public
pi
also
take
respons
report
result
particip
express
would
like
receiv
studi
result
public
studi
outcom
compris
public
studi
whole
encourag
particip
daili
symptom
diari
modifi
jackson
symptom
score
grace
bird
wrote
current
hdec
approv
version
protocol
protocol
manuscript
input
iren
braithwait
jame
fingleton
richard
beasley
iren
braithwait
jame
fingleton
alex
semprini
design
studi
direct
project
mark
weatheral
design
verifi
randomis
schedul
statist
analysi
method
meik
dilcher
lanc
jen
advis
collect
laboratori
analysi
nasopharyng
specimen
steve
mckinstri
investig
rhinothermi
common
cold
feasibl
studi
contribut
develop
protocol
jame
harper
iri
koorevaar
contribut
protocol
amend
studi
fund
fisher
paykel
healthcar
limit
fph
fph
also
provid
rhinothermi
sham
rhinothermi
devic
associ
consum
invit
take
part
screen
process
see
elig
studi
effect
inhal
warm
humidifi
air
common
cold
flu
whether
take
part
screen
cold
flu
studi
choic
nt
want
take
part
nt
give
reason
wo
nt
affect
care
receiv
want
take
part
chang
mind
later
pull
time
particip
inform
sheet
help
decid
whether
would
like
complet
screen
test
studi
set
test
need
done
see
elig
either
cold
flu
studi
go
inform
answer
question
may
need
make
sure
enrol
either
cold
flu
studi
within
hour
develop
cold
flu
symptom
may
short
time
review
materi
decid
whether
proceed
decid
may
want
talk
studi
peopl
famili
friend
healthcar
provid
feel
free
agre
take
part
screen
test
ask
sign
electron
consent
form
given
copi
particip
inform
sheet
consent
form
keep
screen
test
elig
either
cold
flu
studi
wish
take
part
provid
separ
consent
form
screen
process
approv
southern
health
disabl
ethic
committe
document
page
long
includ
consent
form
pleas
make
sure
read
understood
page
screen
process
involv
number
step
make
sure
right
age
studi
nt
medic
condit
take
medic
might
make
inelig
either
studi
make
sure
comfort
abl
complet
task
either
studi
make
sure
happi
usual
doctor
advis
enrol
cold
flu
studi
end
one
ask
fill
two
questionnair
one
flu
symptom
b
one
common
cold
symptom
depend
answer
two
symptom
questionnair
may
ask
provid
us
sampl
back
nose
take
swab
one
nostril
sampl
test
presenc
absenc
flu
viru
neg
test
flu
nose
swab
cold
symptom
score
meet
entri
criteria
advis
elig
cold
studi
receiv
separ
inform
consent
form
cold
studi
outlin
process
specif
studi
posit
test
flu
nose
swab
flu
symptom
questionnair
meet
entri
criteria
advis
elig
flu
studi
pleas
note
femal
particip
reach
point
ask
undertak
urinari
pregnanc
test
pregnant
femal
exclud
flu
studi
b
elig
particip
receiv
separ
inform
consent
form
flu
studi
outlin
process
specif
studi
may
peopl
wrong
combin
cold
flu
symptom
flu
test
result
suitabl
either
studi
suitabl
reimburs
time
travel
enrol
either
studi
ask
first
five
day
studi
take
one
randomis
treatment
refrain
leav
greater
wellington
region
beyond
upper
hut
paraparaumu
exist
travel
plan
requir
leav
greater
wellington
region
advis
elig
studi
nostril
swab
need
take
pain
peopl
may
find
unpleas
uncomfort
requir
second
perform
taken
train
staff
anticip
risk
particip
screen
process
particip
screen
process
cost
anyth
reimburs
allevi
cost
travel
injur
result
treatment
given
part
studi
unlik
elig
compens
acc
howev
compens
f
r
p
e
e
r
r
e
v
e
w
n
l
avail
studi
sponsor
fisher
paykel
healthcar
line
industri
guidelin
give
copi
guidelin
wish
abl
take
action
court
disagre
amount
compens
offer
privat
health
life
insur
may
wish
check
insur
take
part
studi
affect
cover
take
part
screen
entir
voluntari
choic
free
withdraw
screen
time
without
give
reason
staff
overse
screen
process
may
also
stop
continu
decid
best
interest
continu
respect
person
inform
screen
inform
label
code
link
code
name
address
identifi
inform
held
research
staff
materi
could
person
identifi
use
report
studi
screen
process
told
whether
elig
either
studi
elig
one
studi
receiv
separ
inform
consent
sheet
studi
chang
mind
screen
process
abl
particip
either
cold
flu
studi
data
collect
screen
process
kept
secur
locat
mrinz
least
year
follow
studi
complet
enrol
either
cold
flu
studi
nostril
swab
alreadi
taken
store
may
sent
laboratori
christchurch
new
zealand
confirmatori
test
sampl
store
result
studi
publish
point
destroy
elig
particip
either
common
cold
influenza
studi
may
provid
devic
deliv
warm
humidifi
air
purpos
studi
devic
properti
sponsor
taken
use
outsid
area
studi
undertaken
greater
wellington
region
enabl
locat
devic
trace
devic
geoloc
function
similar
googl
locat
servic
collect
locat
data
devic
taken
outsid
studi
area
mrinz
sponsor
notifi
period
approxim
locat
devic
sent
databas
sponsor
secur
server
serial
number
devic
also
collect
f
r
p
e
e
r
r
e
v
e
w
n
l
sponsor
access
person
detail
name
address
date
birth
held
mrinz
locat
data
collect
directli
devic
store
databas
sponsor
secur
server
access
inform
limit
number
authoris
employe
sponsor
abl
access
locat
data
howev
locat
data
activ
monitor
mean
check
use
unless
devic
move
outsid
greater
wellington
region
report
miss
mrinz
devic
move
outsid
greater
wellington
region
sponsor
mrinz
notifi
sponsor
provid
mrinz
locat
inform
mrinz
also
provid
inform
devic
report
miss
inform
use
ensur
locat
devic
trace
unless
devic
move
outsid
greater
wellington
region
mrinz
report
devic
miss
inform
monitor
access
devic
move
outsid
greater
wellington
region
devic
report
miss
mrinz
inform
provid
mrinz
order
locat
devic
devic
return
mrinz
sponsor
delet
inform
will
consent
collect
use
storag
inform
may
elig
particip
studi
question
concern
complaint
screen
process
stage
contact
phone
email
decid
withdraw
screen
agre
inform
collect
point
withdraw
may
continu
process
consent
gp
current
provid
inform
particip
flu
cold
studi
enrol
signific
abnorm
result
obtain
studi
agre
type
tissu
sampl
sent
oversea
awar
sampl
dispos
use
establish
guidelin
discard
biohazard
wast
agre
approv
auditor
appoint
new
zealand
health
disabl
ethic
committe
relev
regulatori
author
approv
repres
review
relev
medic
record
sole
purpos
check
accuraci
inform
record
studi
understand
particip
studi
confidenti
materi
could
identifi
person
use
report
studi
read
section
geoloc
devic
consent
collect
use
storag
locat
data
understand
compens
provis
case
injuri
studi
know
contact
question
studi
gener
screen
test
found
met
criteria
common
cold
studi
studi
effect
inhal
warm
humidifi
air
common
cold
whether
take
part
studi
choic
nt
want
take
part
nt
give
reason
wo
nt
affect
care
receiv
want
take
part
chang
mind
later
pull
time
particip
inform
sheet
help
decid
whether
would
like
particip
studi
set
schedul
task
visit
need
complet
studi
go
inform
answer
question
may
need
make
sure
enrol
common
cold
studi
within
hour
develop
symptom
may
short
time
review
materi
decid
whether
proceed
decid
may
want
talk
studi
peopl
famili
friend
healthcar
provid
feel
free
studi
carri
research
medic
research
institut
new
zealand
mrinz
support
fisher
paykel
healthcar
make
rhinothermi
devic
sponsor
studi
lead
investig
xxxwho
contact
phone
number
page
one
would
like
speak
directli
agre
take
part
studi
ask
sign
electron
consent
form
given
copi
document
sign
inform
consent
form
keep
common
cold
frequent
ill
experienc
peopl
worldwid
mani
peopl
experienc
cold
lifetimesadult
averag
may
suffer
cold
per
year
symptom
last
week
although
peopl
get
better
treatment
may
signific
impact
live
impact
includ
time
work
us
alon
estim
cost
economi
billion
find
differ
way
reduc
impact
common
cold
usual
caus
viru
mani
human
rhinoviru
common
inhal
steam
becom
focu
research
thought
breath
steam
nose
may
kill
viru
well
reduc
symptom
number
day
peopl
remain
unwel
peopl
familiar
steam
therapi
like
hold
face
bowl
steam
hot
water
towel
head
rhinothermi
therapi
deliv
warm
humidifi
air
nostril
lung
via
nasal
prong
aim
studi
show
whether
rhinothermi
chang
symptom
length
sever
andor
reduc
number
day
lost
ill
also
aim
assess
thing
like
often
peopl
use
rhinothermi
home
common
cold
virus
peopl
pictur
person
receiv
rhinothermi
shown
studi
compar
two
differ
regimen
rhinothermi
treatment
common
cold
two
therapi
deliv
warm
humidifi
air
nostril
differ
set
believ
one
regimensset
like
effect
studi
find
true
studi
run
day
total
start
day
treatment
finish
day
record
symptom
diari
today
day
sign
inform
consent
form
ask
refrain
use
cold
flu
treatment
durat
studi
day
absolut
necessari
take
paracetamol
antiinflammatori
medic
eg
ibuprofen
ask
refrain
leav
greater
wellington
region
first
five
day
studi
take
one
two
possibl
treatment
show
complet
onlin
symptom
diari
record
medic
taken
cold
flu
remedi
paracetamol
etc
day
next
day
record
common
cold
symptom
daili
next
day
f
r
p
e
e
r
r
e
v
e
w
n
l
randomis
one
two
possibl
rhinothermi
treatment
regimen
deliv
rhinothermi
differ
set
chanc
either
treatment
like
toss
coin
show
use
rhinothermi
devic
today
home
next
day
also
receiv
first
day
treatment
today
treatment
compon
complet
day
head
home
advis
gp
enrol
studi
day
take
randomis
treatment
fill
onlin
diari
day
final
day
treatment
would
like
come
taken
treatment
need
bring
rhinothermi
devic
back
clinic
check
gener
health
need
fill
onlin
diari
ask
complet
toler
questionnair
devic
next
time
contact
via
phone
call
day
day
day
keep
fill
onlin
diari
day
final
day
studi
call
make
sure
complet
diari
check
gener
health
arrang
reimburs
particip
studi
nostril
swab
nostril
swab
need
take
pain
peopl
may
find
unpleas
uncomfort
requir
second
perform
taken
train
staff
rhinothermi
devic
alway
use
per
instruct
manual
given
appropri
user
manual
train
provid
inform
use
devic
devic
alarm
sound
event
water
level
chamber
low
check
alarm
work
show
test
alarm
use
concern
use
devic
pleas
use
refrain
use
abl
contact
studi
investig
discuss
concern
found
earlier
version
rhinothermi
devic
well
toler
small
number
particip
report
mild
headach
resolv
soon
stop
use
devic
peopl
find
feel
warm
humidifi
air
uncomfort
also
small
number
case
report
devic
alarm
function
work
harm
caus
abl
stop
use
rhinothermi
devic
stage
concern
peopl
get
runni
nose
block
nose
use
devic
goe
away
stop
use
devic
also
small
risk
damag
skin
around
nose
lip
get
noseble
use
devic
rare
like
f
r
p
e
e
r
r
e
v
e
w
n
l
happen
devic
use
longer
period
time
devic
use
paus
stop
time
studi
visit
problem
happen
rhinothermi
devic
contain
plate
heat
warm
water
chamber
care
must
taken
insert
remov
chamber
immedi
use
heater
plate
still
hot
risk
use
electr
power
rhinothermi
devic
humidifi
air
electr
shock
burn
tube
melt
avoid
crosscontamin
cold
make
sure
share
devic
anyon
els
studi
investig
may
also
stop
continu
studi
decid
best
interest
continu
sponsor
mrinz
may
stop
studi
safeti
concern
alreadi
read
screen
particip
inform
sheet
rhinothermi
devic
taken
use
outsid
area
studi
undertaken
greater
wellington
region
enabl
locat
devic
trace
devic
geoloc
function
similar
googl
locat
servic
collect
locat
data
detail
inform
pleas
refer
screen
particip
inform
sheet
studi
fund
fisher
paykel
healthcar
particip
studi
cost
anyth
paid
day
cover
expens
associ
particip
studi
complet
part
studi
part
paid
proport
reflect
far
got
studi
injur
result
treatment
given
part
studi
unlik
elig
compens
acc
howev
compens
avail
studi
sponsor
fisher
paykel
healthcar
line
industri
guidelin
give
copi
guidelin
wish
abl
take
action
court
disagre
amount
compens
offer
privat
health
life
insur
may
wish
check
insur
take
part
studi
affect
cover
take
part
studi
entir
voluntari
choic
free
withdraw
studi
time
without
give
reason
staff
overse
studi
may
also
stop
continu
decid
best
interest
continu
respect
person
inform
therapi
use
rhinothermi
devic
automat
record
analys
part
studi
paperbas
electron
record
studi
held
secur
mrinz
avail
research
staff
audit
studi
f
r
p
e
e
r
r
e
v
e
w
n
l
electron
store
data
may
held
new
zealand
oversea
encrypt
access
limit
appropri
author
nonelectron
studyrel
inform
label
code
link
code
name
address
identifi
inform
held
research
staff
analys
data
includ
result
may
publish
studi
data
report
publish
place
data
repositori
electron
store
place
request
publish
data
deidentifi
individu
identifi
result
data
seen
sometim
southern
health
disabl
ethic
committe
auditor
may
want
make
sure
mrinz
run
studi
properli
may
requir
access
inform
collect
studi
satisfi
studi
data
collect
paper
electron
kept
secur
locat
mrinz
least
year
follow
studi
complet
requir
one
provid
interpret
translat
inform
may
friend
famili
member
support
help
understand
risk
andor
benefit
studi
explan
may
requir
queri
concern
regard
right
particip
studi
may
wish
contact
independ
health
disabl
advoc
free
phone
free
fax
email
ask
make
best
effort
follow
studi
procedur
rhinothermi
devic
still
commerci
develop
fisher
paykel
healthcar
ask
sign
confidenti
statement
consent
form
agre
keep
inform
relat
studi
confidenti
take
part
studi
entir
voluntari
choic
decis
whether
take
part
affect
healthcar
way
futur
relationship
hospit
gp
wish
take
part
studi
free
withdraw
time
without
give
reason
doctor
overse
studi
may
also
stop
continu
studi
decid
best
interest
continu
end
studi
give
summari
result
result
email
post
may
delay
take
part
studi
receiv
result
whole
studi
need
finish
result
analys
end
studi
withdraw
studi
day
collect
studi
relat
materi
unless
specif
request
us
keep
analys
data
collect
f
r
p
e
e
r
r
e
v
e
w
n
l
usual
swab
take
back
nose
day
visit
destroy
lab
studi
result
publish
pleas
note
rhinothermi
devic
yet
commerci
avail
therefor
avail
use
follow
end
studi
agre
take
part
studi
initi
chang
mind
stop
time
without
give
reason
understand
particip
studi
confidenti
materi
could
identifi
person
use
report
studi
need
interpret
pleas
tell
us
believ
particip
understand
studi
given
inform
consent
particip
research
name
signatur
date
particip
confidenti
statement
understand
concept
studi
devic
accompani
inform
anyth
may
learn
becom
awar
within
studi
commerci
sensit
know
must
keep
inform
relat
studi
confidenti
know
must
take
photograph
record
devic
studi
use
devic
home
make
live
awar
oblig
also
understand
oblig
keep
inform
confidenti
particip
name
signatur
date
